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Nitric oxide (NO) is a versatile messenger molecule ﬁ  rst associated with endothelial relaxing 
effects. In the central nervous system (CNS), NO synthesis is primarily triggered by activation of 
N-methyl-D-aspartate (NMDA) receptors and has a Janus face, with both beneﬁ  cial and harmful 
properties. There are three isoforms of the NO synthesizing enzyme nitric oxide synthase 
(NOS): neuronal (nNOS), endothelial (eNOS), and inducible nitric oxide synthase (iNOS), each 
one involved with speciﬁ  c events in the brain. In the CNS, nNOS is involved with modulation of 
synaptic transmission through long-term potentiation in several regions, including nociceptive 
circuits in the spinal cord. Here, we review the role played by NO on central pain sensitization.
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(Stuehr and Grifﬁ  th, 1992), and is expressed in 
response to inﬂ  ammatory and proinﬂ  ammatory 
mediators acting on macrophages, astrocytes and 
microglia (Marletta, 1994). Though traditionally 
only nNOS has been associated with nitrergic sign-
aling in the brain, there have been many evidences 
showing that eNOS also contributes to the physi-
ological actions of NO in the brain parenchyma 
(Garthwaite, 2008). NO is very stable in low, physi-
ological concentrations (Garthwaite, 2008) and is 
produced stoichiometrically after the conversion 
of L-arginine to citrulline in a process requiring 
both NADPH and O2 as co-substrates, and other 
cofactors (Marletta, 1993; Moncada et al., 1989; 
Vincent, 1994) (Figure 1). It is useful to divide 
the chemical reactions in which NO takes part as 
either direct or indirect (Wink et al., 2000). Direct 
reactions occur between low concentrations of 
NO and iron-containing proteins, such as gua-
nylate cyclase (GC), and is responsible for most 
physiological actions of NO (Wink et al., 2000). 
Indirect reactions, conversely, occur when high 
concentrations of NO are present and generate 
INTRODUCTION
Nitric oxide (NO) is one of the most intriguing 
molecules to be found in the brain. This versa-
tile neuronal messenger was ﬁ  rst identiﬁ  ed as an 
endothelium-derived relaxing factor (EDRF), 
responsible for smooth muscle relaxation (Ignarro 
et al., 1987; Palmer et al., 1987). NO is freely dif-
fusible across cell membranes and is synthesized 
by a group of enzymes, known as nitric oxide 
synthases (NOS), from L-arginine and different 
cofactors, depending on the cell type (Hobbs 
and Ignarro, 1996; Lipton et al., 1994; Marletta 
et al., 1998). Three members of the NOS family of 
enzymes have been identiﬁ  ed in mammals: neu-
ronal NOS (nNOS), endothelial NOS (eNOS) and 
inducible NOS (iNOS), which have distinct func-
tional and structural features (see Stuehr et al., 
2004). Both nNOS (also known as Type I) and 
eNOS (Type III) activities are controlled by Ca2+- 
calmodulin and are expressed constitutively in the 
brain (Alderton et al., 2001); iNOS (Type II), on 
the other hand, once expressed is always active, 
being   independent of intracellular Ca2+ levels 
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In the Peripheral Nervous System (PNS), NO 
induces the relaxation of smooth muscle cells in 
the gastrointestinal tract (Bult et al., 1990) and the 
corpus cavernosum (Toda et al., 2005). In the CNS, 
NO is a neurotransmitter (Bredt et  al., 1991), 
albeit an unconventional one due to its free dif-
fusion through aqueous and lipid compartments. 
NOS is physiologically active at nanomolar con-
centrations and is remarkably stable within this 
range (Garthwaite, 2008). After being synthesized, 
NO can act on both postsynaptic and presynaptic 
structures by way of a GC transduction mecha-
nism that eventually increases the intracellular 
levels of the second messenger cyclic guanos-
ine monophosphate (cGMP) (Vincent, 1994). 
There are hints, however, that other transduc-
tion mechanisms might be engaged by NO (see 
Garthwaite, 2008 for review). NO is involved 
with other important functions in the normal 
brain, including regulation of blood ﬂ  ow, neu-
rogenesis, and synaptic plasticity (Estrada and 
DeFelipe, 1998; Holscher, 1997; Moreno-Lopez 
et al., 2000; Wiesinger, 2001). It is also associated 
with the long-term potentiation (LTP) of synaptic 
connections (Brenman and Bredt, 1996) and can 
act as an anti-apoptotic factor when produced 
in normal concentrations (see Blaise et al., 2005 
for a review). Conversely, following injury of the 
brain, NO acts as a   neurodegenerative agent, 
contributing to neuronal death (Cassina et al., 
2002; Guimarães et al., 2009; Kawase et al., 1996). 
Several neurodegenerative disorders of the CNS 
reactive nitrogen oxide species (RNOS) and reac-
tive oxygen species (ROS), such as the powerful 
oxidant peroxynitrite (ONOO–), that can cause 
harmful effects on cells, though nitrosative and 
oxidative stress (Wink et al., 2000).
This Janus face of NO, representing its poten-
tial for both protective and deleterious effects in 
the brain, depends mostly on its concentration 
levels and the identity of the acting enzymatic iso-
form (Calabrese et al., 2007; Lipton et al., 1993). 
The cell signaling activity of NO requires only a 
low amount generated by both nNOS and eNOS 
(Esplugues, 2002). The high levels of NO gener-
ated by iNOS are responsible for an increase in 
the amount of both RNOS and ROS (Wink et al., 
2000). The toxic effects of NO are mostly medi-
ated by its oxidation products, particularly the bio-
logical oxidant peroxynitrite (Pacher et al., 2007). 
Knockout mice lacking the iNOS gene, for instance, 
are less affected by ischemic brain injury (Iadecola 
et al., 1997). Oxidative stress is a common feature 
of the pathogenesis of many neurodegenerative 
disorders, such as Alzheimer’s, Parkinson’s, and 
Huntington’s diseases (Guix et al., 2005; Moreira 
et al., 2005). Peroxynitrite generation, speciﬁ  cally, 
has been singled out as an important pathogenic 
mechanism behind those disorders (Pacher et al., 
2007; Saha and Pahan, 2006). Interestingly, neu-
rons that express nNOS are notoriously resistant 
to many types of injury, including intoxication by 
heavy metals (Freire et al., 2007) and NO-induced 
neurotoxicity (Firestein and Bredt, 1999).
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Figure 1 | Nitric oxide synthesis. Diagram showing the synthetic pathway responsible for nitric oxide (NO) production 
from arginine and O2 and catalyzed by the enzyme nitric oxide synthase (NOS). Cofactors include reduced nicotinamide 
adenine dinucleotide phosphate (NADPH), tetrahydrobiopterin (BH4), ﬂ  avin mononucleotide (FMN), and ﬂ  avin adenine 
dinucleotide (FAD). Synthesis of NO can be pharmacologically abolished by the action of the N-omega-nitro-L -arginine 
methyl ester (L -NAME), an inhibitor of both nNOS and eNOS. Abbreviations: Ca+2/CaM: Calcium/calmodulin; cGMP: 
cyclic guanosine monophosphate; GC: guanylate cyclase; PKG: protein kinase G.Frontiers in Neuroscience  www.frontiersin.org  September  2009 | Volume  3 | Issue  2 | 177
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Xiao et al., 1996). In the rat brain, for instance, 
it was shown that NADPH-d neurons amount 
to approximately 2% of the whole cortical cell 
population (Valtschanoff et  al., 1993; Vincent 
and Hope, 1992). NADPH-d/NOS neurons were 
also detected in the spinal cord (Anderson, 1992; 
Dun et al., 1993; Marsala et al., 1997; Valtschanoff 
et al.,  1992b), mainly in superﬁ  cial  laminae 
(Valtschanoff et al., 1992a), with a distribution 
pattern very similar to PKG (Tao et al., 2000). The 
development of hyperalgesia in the rat’s hindpaw 
is followed by nNOS up-regulation in the spinal 
cord (Lam et al., 1996; Yonehara et al., 1997). In 
our research paper (Freire et al., 2008), we char-
acterized the distribution and morphometric 
aspects of NADPH-d/NO neurons in the spinal 
cord of the agouti, a medium-sized terrestrial and 
burrowing rodent with a widespread distribution 
over Central and South American Neotropical 
forests (Silvius and Fragoso, 2003) that rely mostly 
on a frugivorous diet, usually manipulating seeds 
with high dexterity (Henry, 1999).
We showed that in this species, similar to the 
rat (Valtschanoff et al., 1992a), NADPH-d/NOS 
cells are detected mainly in laminae I–IV and X 
along the entire length of the spinal cord and in 
the intermediolateral column (IML) of both the 
thoracic and lumbar segments. In addition, we 
showed that NOS/NADPH-d neuropil is usually 
more reactive in the dorsal horn of both the cervi-
cal and lumbar enlargements than in the thoracic 
segments of the agouti. NOS/NADPH-d neu-
rons also concentrate around the central canal 
 (lamina  X)  (Freire et al., 2008), which has been 
shown to receive input from visceral and cutane-
ous noxious inputs (Wall et al., 2002; Willis et al., 
1999). Pain information from lamina X ascends to 
the brain through the dorsal column, blurring the 
lines separating the “touch” and “pain” pathways 
(Willis et al., 1999).
HYPERALGESIA, PAIN AND NITRIC OXIDE
Pain, as a sensation, is notoriously difﬁ  cult 
to deﬁ  ne in scientiﬁ  c terms, mostly due to its 
 affective-emotional component. The International 
Association for the Study of Pain (IASP) offers 
the following deﬁ  nition of pain: “An unpleasant 
sensory and emotional experience associated with 
actual or potential tissue damage, or described 
in terms of such damage”. Damage is signaled to 
the brain by specialized high-threshold receptors 
spread all over the body, both externally and inter-
nally and associated with small, slow- conducting 
unmyelinated ﬁ  bers. Pain signals enter the brain 
through neurons located in ganglia in the spi-
nal cord and the brainstem. In the spinal cord, 
nociceptors make synapse with projection neu-
are related to the excessive activation of NMDA 
receptors, including stroke and amyotrophic 
 lateral   sclerosis  (Lipton and Rosenberg, 1994). 
Since NMDA receptor activation is the primary 
stimulus for NO synthesis, it has been   suggested 
that it might have a role in NMDA-mediated neu-
rodegeneration. This has been conﬁ  rmed in stud-
ies of nNOS knockout mice, which are resistant 
to excitotoxicity following acute ischemic injury 
(Huang et al., 1994).
All three NOS types are dependent on NADPH 
as a co-factor for their activity (Marletta, 1994). 
Since the early 1960’s, it has been known that 
histochemistry to reveal the activity of the oxi-
doreductase enzyme nicotinamide adenine 
dinucleotide phosphate diaphorase (NADPH-d) 
histochemistry is associated with a sub- population 
of inhibitory neurons in the mammalian CNS 
(Thomas and Pearse, 1964). Any enzyme of the 
NADPH-d family catalyzes the transfer of elec-
trons from NADPH to the colorless salt nitrob-
lue tetrazolium (NBT), producing a colored, 
water-insoluble formazan dye which is visible 
through light microscopy (see Scherer-Singler 
et al., 1983 for details). Though in unﬁ  xed tis-
sue many enzymes show a NADPH-d activity, 
it was demonstrated that in ﬁ  xed tissue most of 
these enzymes are inactivated and only those of 
the NOS family retain their NADPH-d activity 
(Dawson et al., 1991; Hope et al., 1991).
Accordingly, NADPH-d has been widely used 
to detect NOS activity in aldehyde-ﬁ  xed tissue in 
both the normal (Freire et al., 2005; Sandell, 1986; 
Wiencken and Casagrande, 2000) and altered CNS 
(Freire et al., 2007; Stojkovic et al., 1998; Wallace 
et al., 1996), revealing two distinct types of non-
pyramidal cells: a more reactive group, with a 
Golgi-like appearance (type I cells) and a small 
and more weakly reactive population (type  II 
cells) (Luth et al., 1994). Both are co-localized 
with GABA in cortical neurons (Yan et al., 1996). 
Type I neurons have large, darkly stained cell bod-
ies and dendritic trees (Luth et al., 1994) and are 
present in the brain of all mammals examined, 
from monotremes to primates (Hassiotis et al., 
2005; Yan and Garey, 1997). Type II neurons, con-
versely, are weakly stained, with small cell bodies 
and few or no labeled processes (Luth et al., 1994), 
and are reported to be especially numerous in 
the primate brain (Sandell, 1986; Yan and Garey, 
1997). Both cell groups constitute an important 
source of NO in the CNS.
The distribution of NADPH-d neurons has 
already been described in the CNS of several 
mammalian orders (Barone and Kennedy, 2000; 
Luth et al., 1994; Mizukawa et al., 1989; Pereira 
et  al., 2000; Wiencken and Casagrande, 2000; 
Nitric oxide
Small hydrophobic molecule with 
a short half-life and freely diffusible 
across cell membranes, with several 
functions in the normal and diseased 
central nervous system. It is synthesized 
by a group of enzymes called nitric 
oxide synthases (NOS).
Pain
An unpleasant sensation that can range 
from mild to severe, caused by injury 
or illness, but sometimes with no 
apparent etiology, generating anxiety 
and discomfort.Frontiers in Neuroscience  www.frontiersin.org  September  2009 | Volume  3 | Issue  2 | 178
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LTP mediated hyperalgesia occurs with the 
contribution of projection neurons in lamina I 
expressing the neurokinin 1 (NK1)   receptor 
(Ikeda et  al., 2006). The presence of NO is 
  essential for induction of LTP in lamina I neu-
rons (Ikeda et al., 2006). In rats, the main source 
of NO in lamina  I neurons are   interneurons 
located in laminae II and III (Ruscheweyh et al., 
2006). Recently, a study using some speciﬁ  c 
inhibitors for distinct NOS   isoforms (Tanabe 
et al., 2009) showed that both nNOS and iNOS 
are involved with hyperalgesia. However, while 
nNOS has a deﬁ  nite role in spinal cord circuits, 
there is some disagreement whether iNOS also 
participates in central transmission (Tanabe 
et al., 2009) or it expressed only peripherally 
(De Alba et  al., 2006) in both inﬂ  ammatory 
and neuropathic pain   models. Strong noxious 
stimuli lead to the   activation of downstream 
serine/threonine   protein kinases, including 
cAMP-dependent protein kinase (PKA), Ca+2/
phospholipid-  dependent protein kinase (PKC), 
Ca+2/calmodulin-  dependent protein kinase II 
(CaMKII), and (cGMP)-  dependent protein 
kinase (PKG) (Ji et  al., 2003; Tanabe et  al., 
2009; Wu et al., 2005), some of which with an 
 effective participation of NO. Brieﬂ  y, the general 
mechanism by which NO participates in spinal 
nociceptive processing consists in the activation 
of soluble GC, which in turn   generates cGMP. 
Intracellular elevation of the cGMP levels may 
further activate PKG (see Figure 2). Otherwise, 
NO may produce  peroxynitrite by rapidly  reacting 
with superoxide (Beckman et al., 1990), whose 
importance in enhancing   phosphorylation of 
NMDA receptors, and  consequently central sen-
sitization, has been recently suggested in animal 
models of neuropathic and inﬂ  ammatory pain 
(Gao et al., 2007). Besides, the ROS   produced 
by either NO or NMDA-  receptor activation, 
superoxide and peroxynitrite, respectively, 
also contribute to maintenance of hyperalgesia 
(Tanabe et al., 2009), and can stimulate directly 
the pheripheral nociceptive terminals (Aley 
et al., 1998).
The crucial involvement of the NO-GC 
  signaling pathway in inﬂ  ammatory and neu-
ropathic pain is underscored by the markedly 
reduced nociceptive behavior presented by a 
NO-GC knock-out mouse strain (Schmidtko 
et al., 2008). Inhibitors of NOS activity have also 
provided evidence for the role of NO in pain 
sensitization. Yonehara and coworkers (1997), 
in a chronic inﬂ  ammatory pain model, reported 
a decrease in hyperalgesia after the intravenous 
administration of the arginine analog N-omega-
nitro-L-arginine methyl ester (L-NAME), which 
rons located in superﬁ  cial laminae, using neuro-
transmitters such as glutamate, that can directly 
activate them, and the neuropeptides substance 
P (SP) and neurokinin A (NKA), which modulate 
neuronal output in more subtle ways. Both SP and 
NKA are expressed through the preprotachykinin 
A (PPT-A) gene and bind to the neurokinin-1 
(NK-1) receptor (Todd et al., 2002). Most of the 
spinal cord neurons in lamina I that possess the 
NK-1 receptor belong to the spinothalamic and 
spinoparabrachial tracts, that send ascending 
nociceptive information to the brain.
When subjected to a regime of repetitive stim-
ulation resulting from persistent tissue injury, 
nerve damage or electrical stimulation, spinal 
cord circuits are reorganized and pain is exacer-
bated in a process called nociceptive sensitization 
(Wall and Woolf, 1984; Woolf, 1983). Nociceptive 
sensitization is perceived as a decreased thresh-
old to both noxious and innocuous stimulation, 
called hyperalgesia and allodynia, respectively. 
This effect has the obvious adaptive value of 
forcing the animal to protect the injured site and 
avoid further damage. Nociceptive sensitization 
has both central and peripheral components. 
Peripheral sensitization results from the release 
of inﬂ  ammatory mediators such as prostaglan-
din E2 (PGE2), bradykinin, nerve growth factor 
(NGF), and NO in the injured site (Milligan 
and Watkins, 2009). These chemicals increase 
the sensitivity/  excitability of sensory terminals 
leading to localized tissue effects. Central sensi-
tization, on the other hand, can result from the 
repetitive activation of C-ﬁ  bers and the conse-
quent temporal summation of dorsal horn neu-
ronal responses, termed “windup” (Mendell and 
Wall, 1964). This sensitization operates on mech-
anisms that are broadly similar to those underly-
ing long-term potentiation (LTP) (see Ji et al., 
2003 for a review). As with LTP in the hippocam-
pus,   activity-dependent plastic modiﬁ  cation of 
  synapses between SP peripheral nociceptor ter-
minals and lamina dorsal horn neurons occurs 
through phosphorylation of both α-amino-3-
hydroxyl-5-methyl-4-isoxazole-propionate 
(AMPA) and N-methyl-D-aspartate (NMDA) 
ionotropic receptors and the recruitment of 
AMPA receptors to the postsynaptic membrane 
(Ji et al., 2003) (Figure 2). The complement of 
second   messenger pathways recruited in each 
case is slightly different (Ji et al., 2003). Though 
there is still much debate about speciﬁ  c details 
of the  mechanisms involved, it seems evident 
that NO plays an important role as a signaling 
molecule on LTP in the hippocampus and other 
cortical areas (Haghikia et al., 2007; Hopper and 
Garthwaite, 2006).
LTP
Long-lasting increase in synaptic 
efﬁ  ciency following high-frequency 
stimulation of presynaptic elements. 
It was discovered in the hippocampus 
and depends on either N-methyl-D-
aspartate (NMDA) receptor-dependent 
or -independent mechanisms to be 
evoked and on gene expression 
and protein synthesis to be maintained.
Hyperalgesia
Heightened sensitivity to pain caused 
by injury to peripheral tissues or neural 
elements. It can be elicited by both 
peripheral and central sensitization 
mechanisms. Peripheral mechanisms 
are triggered by inﬂ  ammatory agents 
and the release of intracellular 
molecules by damaged cells. Central 
sensitization can be of the early 
and late-onset types. Early-onset 
sensitization is caused by LTP-like 
mechanisms, while the late-onset type 
involves changes in gene expression.Frontiers in Neuroscience  www.frontiersin.org  September  2009 | Volume  3 | Issue  2 | 179
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cascade of molecular events leading to apoptosis, 
neurogenesis, LTP, etc. The NO-dependent LTP 
of nociceptive pathways in the spinal cord is a 
crucial mechanism behind long-term central pain 
sensitization. The ensuing hyperalgesia and allo-
dynia warns the animal to the need to protect the 
affected region on the periphery. NO is released 
by interneurons in spinal cord’s laminae II and III 
and affects synapses between peripheral nocic-
eptor terminals and lamina I neurons sending 
upward projections to the brain. The amount of 
NOS in this region is upregulated during sensi-
tization and could be responsible for the main-
tenance of LTP.
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inhibits the nNOS and eNOS isoforms (Knowles 
and Moncada, 1994; Parkinson, 2000). More 
recently, however, other groups were also able 
to show the speciﬁ  c role of iNOS in hyperalge-
sia by using highly selective inhibitors for this 
isoform, such as N-(3-[Aminomethyl] benzyl) 
acetamidine (1400W) (Tang et al., 2007) and 
(S)-2-amino-7- acetamidino-5- thioheptanoic 
acid (GW274150) (De Alba et al., 2006). Both 
inhibitors induced a signiﬁ  cant reduction in 
hyperalgesia.
CONCLUSIONS
Since its discovery in the 1980’s, NO has been 
shown to be a key player in many normal and 
pathological events in the brain. In normal condi-
tions, it is produced in every major region of the 
CNS by a speciﬁ  c group of NADPH-d positive 
neurons. NO easily diffuses through cell mem-
branes and gets to the intracellular compartment, 
where it increases the level of the second mes-
senger cGMP (Qian et al., 1996) and initiates a 
Figure 2 | Processing of pain information in the spinal cord. Pain signals 
are transmitted to the dorsal horn by nociceptive terminals that synapse with 
neurons located in laminae I, II, and III. Early-onset activity-dependent central 
sensitization of ascending pathways depends on LTP of the synapse between 
peripheral terminal containing substance P and spinothalamic projection neurons 
in lamina I. Pain sensitization depends, in some level, on nitric oxide (NO) 
released by interneurons located in laminae II and III and also by glial cells. 
Abbreviations: AMPAr: α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
receptor; NMDAr: N-methyl-D-aspartate receptor; NK1r: neurokinin 1 receptor; 
Glu: glutamate; Ins(1,4,5)P3: Inositol 1,4,5-triphosphate; CaMKII: calcium/
calmodulin-dependent protein kinase II; PKA: protein kinase A; PKC: protein 
kinase C; PKG: protein kinase G; NOS: nitric oxide synthase; ERK: extracellular 
signal-regulated kinase; cGMP: cyclic guanosine monophosphate; IL -1β: 
interleukin 1beta; TNFα: tumor necrosis factor-alfa; ROS: reactive oxygen species.Frontiers in Neuroscience  www.frontiersin.org  September  2009 | Volume  3 | Issue  2 | 180
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